These benefits extend to the pulmonary vasculature, where the agents have been shown to mitigate endothelial dysfunction, chronic inflammation, and adverse vascular remodelling, leading to associated improvements in pulmonary arteries [18]
Evidence suggests that tirzepatide may exacerbate diabetic retinopathy in some individuals, so early disclosure allows for appropriate monitoring or the consideration of alternative treatment options, if necessary (MacIsaac et al
[3] [4] Tirzepatide represents a novel pharmacological approach as the first dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved for weight management, distinguishing it from single-mechanism GLP-1 agonists
Synthetic 39-residue lipidated polypeptide investigated as a dual GIP and GLP-1 receptor agonist in preclinical metabolic research
At Learn2Lose, we focus not just on losing weight, but on improving body composition and long-term health
But with Zepbound , not losing weight can mean a few different things, and not all of them signal a problem